Morepen Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.75×	0.79×	0.76×	0.71×	0.69×
	1.03×	1.34×	1.07×	1.08×	1.08×
	10.6%	4.9%	8.0%	7.4%	3.6%
	0.97×	0.97×	1.18×	1.41×	1.32×
	1.67×	1.55×	1.50×	1.53×	1.48×
	13.4%	7.9%	11.5%	12.2%	5.3%
	7.9%	7.9%	11.8%	12.0%	5.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MOREPENLAB₹119.31

Morepen Laboratories Limited

· Pharma & Health

₹ CrorePeersIOLCP INNOVACAP FDC ORCHPHARMA SENORES SANOFI GUJTHEM RPGLIFEMcap ₹6,537 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.69	0.71	0.76	0.79	0.75
Interest Burden (Pretax/EBIT) ×	1.08	1.08	1.07	1.34	1.03
EBIT Margin %	3.64	7.40	8.01	4.94	10.58
Asset Turnover ×	1.32	1.41	1.18	0.97	0.97
Financial Leverage (Assets/Equity) ×	1.48	1.53	1.50	1.55	1.67
ROE (5-step product, year-end total equity) %	5.32	12.24	11.52	7.91	13.35
ROE (owners' profit / average owners' equity) %	5.73	12.02	11.78	7.90	7.90

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.